Outset Medical begins selling TabloCart again after FDA nod
Outset Medical (Nasdaq: OM) announced today that the FDA granted 510(k) clearance for its TabloCart with Prefiltration.
Source: massdevice.com
📰 Sam Eiber News
Sam Eiber News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sam Eiber. Real-time updates on events, politics, business and more.
iRhythm posts Q1 sales beat, FDA warning letter remains on track
IRhythm (Nasdaq: IRTC) shares dipped slightly today on first-quarter results that topped the consensus sales forecast.
Massdevice Medtech Quentin Blackford Marie Thibault Sam Eiber San Francisco Based Zio Mobile Cardiac Telemetry
Source: massdevice.com
Abbott wins FDA approval for dissolving drug-eluting scaffold
Abbott (NYSE: ABT) announced today that the FDA approved its Espirit everolimus-eluting resorbable scaffold system.
Source: massdevice.com
Apple Asks Appeals Court to Reverse Smartwatch Import Ban as Masimo Patent Battle Continues
The tech giant said the decision to ban the watches were made relying on Masimo patents that were “purely hypothetical” when filing the complaint in 2021.
Source: designnews.com
Outset Medical stock soars on optimistic analyst outlook
Outset Medical (Nasdaq: OM) shares ticked up after BTIG analysts initiated coverage with a "Buy" rating for the home hemodialysis company.
Source: massdevice.com
FDA approves Abbott TriClip TEER system
Abbott (NYSE: ABT) announced that the FDA granted approval for its first-of-ts-kind TriClip transcatheter edge-to-edge repair (TEER) system.
Source: massdevice.com
Masimo looks to separate consumer business after $1B buyout
Analysts called the move "a major twist ... likely to be welcomed by shareholders" two years after Masimo's controversial Sound United deal.
Source: massdevice.com
Masimo stock dips despite Street-beating Q4
Masimo shares fell slightly despite fourth-quarter results that came in ahead of the consensus forecast.
Source: massdevice.com
Insulet launches Omnipod 5 with Dexcom G7, sales rise 38% in Q4
Insulet (Nasdaq:PODD) announced today that it began a limited market release of the Omnipod 5 with the Dexcom G7.
Source: drugdeliverybusiness.com
iRhythm stock dips on mixed Q4, guidance 'may disappoint'
IRhythm Technologies (Nasdaq: IRTC) shares took a hit today on third-quarter results that came in mixed compared to the consensus forecast.
Marie Thibault Sam Eiber Quentin Blackford Massdevice Medtech Rhythm Technologies San Francisco Based
Source: massdevice.com